Pharmacists in Hornell, New York


13 Pharmacists found in Hornell
male pharmacist

Adam Harriger, RPH


Pharmacist
1000 Hwy 36 North, Hornell, NY 14843
607-324-3600     607-324-3313

male pharmacist

Brian J Marlatt


Pharmacist
12 Park Dr, Hornell, NY 14843
607-324-6276    

female pharmacist

Casey Lee Curran, PHARMD


Pharmacist
1000 State Route 36, Hornell, NY 14843
607-324-7225     607-324-7363



female pharmacist

Mrs. Catherine Angela Bergquist, RPH


Pharmacist
1 Bethesda Dr, Hornell, NY 14843
607-324-6935    

male pharmacist

Mr. Eric Thomas Booth, RPH


Pharmacist
1000 State Route 36, Hornell, NY 14843
607-324-7225     607-324-7363

male pharmacist

Mr. Irfan Majid Mehr, RPH


Pharmacist
12 Park Dr, Hornell, NY 14843
607-324-6276     607-324-1976

female pharmacist

Julia F Lewis, PHARM D


Pharmacist
1000 State Route 36, Hornell, NY 14843
607-324-7225     607-324-7363

female pharmacist

Kathryn Meghan Donohue, PHARM.D.


Pharmacist
79 Crosby St, Hornell, NY 14843
585-201-6225    

male pharmacist

Patrick Dunn, RPH


Pharmacist
1000 State Route 36, Hornell, NY 14843
607-324-7363    

male pharmacist

Randolph Jay Weaver, RPH


Pharmacist
181 Seneca St, Hornell, NY 14843
607-324-2212     607-324-2243

male pharmacist

Rick Roger Bergquist, RPH


Pharmacist
1000 Highway 36 North, Attn: Pharmacy Manager, Hornell, NY 14843
607-324-4870     607-324-3313

male pharmacist

Mr. Samuel Michael Patello, B.S.


Pharmacist
12 Park Dr, Hornell, NY 14843
607-324-6276    

female pharmacist

Torie Fyles


Pharmacist
1000 Hwy 36 North, Hornell, NY 14843
607-324-3600    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.